The impending general elections, volatility in rupee and international oil prices are likely to lead to higher gross under recoveries for 2013-14 to around Rs 1,47,500 crore for oil marketing
ITC Paperboards and Specialty Papers, an arm of the ITC group which is witnessing a slowdown in growth, wants to invest around Rs 1100 crore towards revving up their manufacturing
Drug major Sun Pharma today said it has received US health regulator's nod to market a generic version of Eli Lilly & Company's Cymbalta, an anti-depressant drug, in the American
Shasun Pharmaceuticals today said its plans to sell Andhra Pradesh unit are subject to approval of the company's shareholders.
At the company's board meeting it was decided to sell or
The US health regulator has found significant violations of good manufacturing norms at the Indian drug company Jubilant Life Sciences' Washington facility for finished pharmaceuticals.
The manufacturing facilities, Jubilant HollisterStier,
The Securities Appellate Tribunal (SAT) has upheld Sebi's order against an individual in a case related to violations of broker norms and for not furnishing details sought by the market
The Securities Appellate Tribunal (SAT) today upheld Sebi's order against Rose Valley Real Estates And Construction, in a case related to failure of the company to comply with summons issued
Public servants and persons holding statutory positions may soon be prohibited from trading in listed securities of companies whose matters are being handled by them, thus giving them access to
Stay informed on our latest news!
William D. Green
Chairman & CEO, Accenture